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  This study was designed to investigate the potential estrogenic 
effects of perinatal dietary phytoestrogens on the rat uterus. 
Pregnant rats were divided to three groups provided the 
following diets: (1) rat chow, (2) rat chow with 7.5% Trifolium 
(T.) pratense, or (3) rat chow supplemented with 17β-estradiol 
(0.5 mg/kg). The dams in each group were kept on the same 
diet during pregnancy and lactation. Female offspring were 
euthanized on day 21 at which time body and organ weights 
were recorded and tissue samples were taken for histology. 
Immunohistochemistry was performed to detect estrogen 
receptor alpha (ERα) and progesterone receptor (PR) levels. 
Our results revealed estrogen-like biological effects of perinatal 
T. pratense exposure. Relative uterus and ovary weights in the 
experimental groups were increased compared to control. 
The number of uterine glands and luminal epithelium heights 
were also increased. However, there were no statistically 
significant changes detected in the immunostaining intensity 
of ERα and PR between the groups.
Keywords: estrogen receptor alpha, progesterone receptor, rat 
uterus, red clover, Trifolium pratense
Introduction 
 Trifolium  (T.) pratense, a fodder plant, contains 
phytoestrogens that possess putative weak estrogenic or 
anti-estrogenic activity. T. pratense contains four important 
estrogenic isoflavones (biochanin A, formononetin, 
genistein, and daidzein) and coumestans [20]. Early studies 
demonstrated that isoflavone intake was associated with 
impaired fertility in sheep and silage-fed cows exposed to 
isoflavone-rich T. pratense [1,12]. Reportedly, even low 
concentrations of phytoestrogens may have substantial 
deleterious effects on the reproductive rate of sheep, and 
possibly cattle, or may manifest as subclinical infertility in 
the absence of any visible clinical signs [1].
T. pratense is important not only as animal feed but also as 
an alternative to conventional hormone replacement therapy 
due to its high isoflavone content [3]. Although 
phytoestrogens were shown to be responsible for fertility- 
related disorders in animals, they have also been found to 
be beneficial for certain diseases. Extracts obtained from T. 
pratense have been shown to inhibit aromatase activity, 
angiogenesis, and inflammation, and have been tested for 
treatment of breast and prostate cancers [11,15,19,24]. A 
number of clinical trials have been performed to address the 
effects of T. pratense on menopause, cognitive function, and 
bone and cardiovascular health with no agreement on their 
effectiveness [5,8,16]. Further studies are necessary to 
satisfy this controversy and evaluate the risks of long-term 
use of phytoestrogens. Phytoestrogens have generated 
considerable interest because of their potential cancer 
preventive, cardioprotective, and anti-osteoporotic affects, 
as well as their ability to relieve menopausal symptoms. 
There have been contradictory results published on the 
effects of isoflavones on a variety of estrogen-regulating 
organs postulating both beneficial and adverse effects on 
human health [25]. 
Animal studies have indicated that neonatal exposure to 
phytoestrogens and environmental estrogens may affect 
male and female reproductive development [2]. A soy 
isoflavone, genistein, was reported to modulate sex steroid 
receptor expression in prepubertal rat uteri when given at 
considerably high pharmacologic doses [9]. Moreover, 
extracts of T. pratense tested in an adult ovariectomized rat 
model were suggested to be weakly estrogenic [7] or to 
have no effect on rat uterus [18]. 
Compounds with estrogenic activity, which naturally 
occur in food products or fodder plants, may alter the 
reproductive performance of animals and may also have an 
impact on animal and/or human health. Therefore, 
experimental studies based on physiologic dose levels 
evaluating exposure at different periods of life are needed. 
In this study, we investigated whether perinatal exposure to 
T. pratense through dietary intake would alter the uterine 
health of prepubertal rats.122    Emrah Yatkin et al.
Materials and Methods
Adult, female Wistar albino rats (180∼250 g; n = 15) and 
their female littermates (n = 40) were used for this study. 
The experimental protocol was approved by Istanbul 
University’s Animal Care and Use Committee (Approval 
number: 18/13072001) consistent with the NIH Guidelines 
for the Care and Use of Laboratory Animals. The rats were 
maintained under standard laboratory conditions with a 
12:12 light/dark cycle and free access to pellet feed and tap 
water.
Experimental diets and groups
T. pratense was gathered from local fields in the Marmara 
region of Turkey. The plant was identified by Associate 
Professor Dr. Tuna Ekim (Faculty of Pharmacy, University 
of Istanbul, Turkey) as T. pratense L. var. Pratense. A dried 
specimen was deposited in the Herbarium of Istanbul 
University, Faculty of Pharmacy, with registration number 
39935. The areal part of T. pratense was dried in a non-humid 
room at 25
oC and then grinded with a blender. The pulverized 
plant was thoroughly mixed and stored in the dark until the 
time of use. The concentrations of different isoflavones in 
T. pratense were analyzed by Krenn et al. [14]. The extract 
was prepared by maceration with water and extraction of the 
free genins was accomplished with methanol under reflux. 
The concentrations of the isoflavones in our material were 
as follows: biochanin 0.3%, formononetin 0.27%, daidzein 
0.01%, and genistein 0.01%. 
The study consisted of three groups receiving different 
diets as follows: the control group received standard rat diet 
(Eris Yem, Turkey); the T. pratense group included pregnant 
rats fed the control diet mixed with pulverized T. pratense 
(75 g/kg diet); and the estradiol group had 0.5 mg estradiol 
[(17β)-estra-1,3,5(10)-triene-3,17-diol; Sigma, USA] 
dissolved in corn oil (Sigma, USA) added to 1 kg of the 
control diet (12.5 μg/rat/day). The dams were exposed to 
different diets from the seventh day of gestation throughout 
lactation until postpartum day 21 at which time the female 
littermates were euthanized. Daily diet consumption was 
recorded as ∼25 g. Only female littermates were used in the 
experiment. 
Histology and histomorphometric methods
The uteri samples were fixed in Bouin’s solution for 18∼
20 h. After fixation, the samples were dehydrated in ethanol, 
cleared in xylene, and embedded in paraffin. Tissue sections 
were cut at a thickness of 5 μm and stained with hematoxylin 
and eosin. Images were taken with a Microphot FX light 
microscope (Nikon, Japan) and digitized with a CCD camera 
(F10; Panasonic, Japan). Body and uteri weights were 
determined in all groups. Relative weights were calculated 
by dividing organ weights by body weights and multiplying 
by 10,000.
Histometric methods were used to measure uterine layer 
areas and uteri luminal epithelium heights. Each uterine 
horn was cut into four equal pieces and the number of uterine 
glands was counted from these different segments. For 
measurement of uterine layer area, digitalized cross sections 
of the uteri were transferred to the AutoCad 2002 program 
(Autodesk, USA) and a line was drawn around each uterine 
layer using the polyline tool. After transferring the same 
sections to the Corel Draw 12 program (Corel, USA), the 
freehand tool was used to measure the epithelial height at 4∼
6 different points in each section. Calibration was performed 
with a milimetric ruler (1 mm, 0.01 Div; Graticules Pyser- 
Sgi, UK), which was photographed with the same 
magnification as all other images. Measurements of luminal 
epithelial cell height were completed for 10 animals per 
group.
Immunocytochemistry
Progesterone receptor (PR) antibody (rabbit anti-human 
PR, recognizes both forms of PR; Dako, Denmark), and 
estrogen receptor alpha (ERα) antibody (monoclonal 
mouse anti-human ER; Dako, Denmark) were used for 
immunohistochemistry. Paraffin sections were dewaxed 
and rehydrated. After washing in water, the sections 
underwent antigen retrieval in a microwave oven in 10 mM 
sodium citrate buffer, pH 6.0, for 15 min. The sections were 
allowed to cool and then rinsed with phosphate buffered 
saline (PBS). Endogenic peroxidase activity was blocked 
with 1% H2O2 in PBS for 20 min. PR (1:400) and ERα 
(1:200) antibodies were diluted in PBS with 3% bovine 
serum albumin containing 0.05% Tween. The sections were 
incubated with primary antibodies overnight at +4
oC, washed 
with PBS, and incubated with horseradish peroxidase 
conjugated Dako EnVisionTM systems (Dako, Denmark) 
for 30 min. The slides were rinsed twice with PBS and color 
was developed with diaminobenzidine substrate (Dako, 
Denmark). The sections were then counterstained with 
Mayer’s hematoxylin, dehydrated, and mounted. 
Slides were analyzed using light microscopy. The number 
and distribution of ERα and PR stainings were determined 
from uteri sections of five animals in each group at ×200 
magnification. Uterine structures, namely luminal/glandular 
epithelium, circular/longitudinal muscle, and stroma, were 
analyzed. The proportional score of positively stained cells 
was evaluated and given a score of zero for no staining, 1 
for weak staining, 2 for moderate staining, 3 for strong 
staining, and 4 for intense staining. The proportional score 
reflected the number of nuclear ERα and PR positive 
epithelial cells in the layers of the uteri. 
Statistics
Statistical analyses were performed using Windows SPSS 
(ver. 10.0; SPSS, USA) with Duncan’s one-way ANOVA 
test. P value ＜ 0.05 was considered significant. Effects of T. pratense on rat uterus    123
Table 1. Body weights and relative ovaria and uteri weights
Control  T. pratense Estradiol 
Body weights (g) 23.89 ± 2.41 21.4 ± 1.66 19.87 ± 0.43
Relative ovaria 
weights
  5.98 ± 0.19 6.87 ± 0.2*   5.68 ± 0.27
Relative uterus 
weights
  5.85 ± 0.24   7.23 ± 0.21*     7.14 ± 0.42*
Body and uteri weights from control, Trifolium (T.) pratense, and 
estradiol groups. Relative weights were calculated by dividing organ
weights by body weights and multiplying by 10,000 (n = 10 per group).
*p ＜ 0.01 significantly different compared to control group. All data
represent mean ± SD.
Table 2. Number of uterine glands and luminal epithelial cell height
Control  T. pratense Estradiol 
Number of 
uterine glands
2.19 ± 0.10 
(81)
  2.49 ± 0.12* 
(50)
  2.93 ± 0.09* 
(52)
Luminal 
epithelial cell 
height (μm)
11.34 ± 0.11 
(189)
11.99 ± 0.07* 
(228)
12.22 ± 0.08* 
(184)
*p ＜ 0.001 significantly different compared to control group. All 
data represent mean ± SD (n).
Table 3. Endometrium, myometrium, and total area of uterine layers
 Control  T. pratense Estradiol
Myometrium 
(mm
2)
0.190 ± 0.006 
(81)
0.198 ± 0.006 
(50)
0.198 ± 0.006 
(52)
Endometrium 
(mm
2)*
0.120 ± 0.004 
(81)
  0.132 ± 0.039* 
(50)
  0.134 ± 0.005* 
(52)
Total uterine 
area (mm
2)
0.310 ± 0.009 
(81)
0.330 ± 0.009 
(50)
0.332 ± 0.010 
(52)
*p ＜ 0.05 shows significant differences compared to control group.
Endometrium area is significantly bigger in T. pratense and estradiol
treated groups. All data represent mean ± SD (n).
Results
Body, ovaria, and uteri weights
Treatment of rats from gestation day 7 to postnatal day 21 
with T. pratense or with estradiol, slightly decreased body 
weights, but this decrease was not statistically significant 
(Table 1). Relative ovaria weights were significantly 
increased only in the T. pratense group. T. pratense caused 
a statistically significant increase in relative uterine 
weights with a similar increase also found in the estradiol 
group (Table 1). 
Morphometric analysis
The number of uterine glands was significantly increased 
in animals treated with T. pratense or estradiol (Table 2). 
Luminal epithelial cell height was significantly increased 
in both T. pratense and esteradiol treated animals compared 
to control animals (Table 2) and endometrium volumes 
were significantly increased in both T. pratense and 
estradiol groups as well (Table 3). 
ERα and PR immunostaining
ERα and PR positive nuclei were localized in the epithelial, 
stromal, and muscular cells of the uteri (Fig. 1). Uterine 
sections not receiving primary antibody showed no staining. 
Strong PR immunoactivity was observed in the luminal 
epithelium of uterine tubes but only faint staining was 
observed in T. pratense and estradiol treated groups (Fig. 1). 
The staining intensity of glandular, luminal, stromal, and 
muscular compartments for ERα in the uteri of rats was 
reduced in both T. pratense and estradiol treated animals 
compared to controls (Fig. 2A); however, this decrease was 
not statistically significant. PR staining intensity decreased 
in luminal and glandular compartments in T. pratense and 
estradiol treatment groups. No changes were observed in the 
staining intensity of muscular and stromal layers between 
the control and estradiol groups. Decreased stromal staining 
intensity was observed in the T. pratense group compared 
to the control group. No PR staining was observed in the 
muscular layer of T. pratense treated animals (Fig. 2B). 
Discussion
In the present study, the effects of dietary perinatal exposure 
to T. pratense were investigated in female rats. Dietary 
estradiol was used as a reference compound for estrogenicity. 
In addition to isoflavones, T. pratense contains other 
potentially important components including phenolic acids 
and flavonoids that may affect uterine health in combination 
with isoflavones. We administered T. pratense by adding it 
to the diet rather than giving it as an extract to simulate the 
consumption of isoflavones through diet.
In agreement with earlier data [14], HPLC analysis showed 
that biochanin A and formononetin were the most abundant 
isoflavones detected in T. pratense, followed by genistein 
and daidzein. Genistein is the major isoflavone found in soy. 
T. pratense differs from soy not only in its lower genistein 
content but also in its higher phytoestrogen content. The 
total amount of isoflavones found in T. pratense extract 
used in the present study (0.61%) was lower than the 
amount reported by Saloniemi et al. [21] (1∼2.5%). The 
low isoflavone content of T. pratense used in the present 
study may be due to the extraction method, seasonal changes, 
temperature (e.g. cool weather during the growing season), 
phosphorus content of the soil, changes in ozone exposure, 124    Emrah Yatkin et al.
Fig. 1. Immunohistochemical expression of estrogen receptor alpha (ERα) in the uterus and progesterone receptor (PR) in the uterus
and uterine tube. M: myometrium, GE: glandular epithelium, E: endometrium, LE: luminal epithelium, L: lumen. Arrows: nuclear 
staining of ERα and PR. Counterstain with Mayer’s hematoxylin. Scale bars = 50 μm.
or differences among T. pratense varieties [4,21-23]. 
Both estradiol and T. pratense treatments slowed the 
growth of pups. Exposure to either estradiol or T. pratense 
throughout pregnancy until day 21 increased relative uterine 
weights, suggesting estrogenic activity. In vitro studies 
demonstrated that T. pratense extracts exhibit estrogenic 
activity in an estrogen-dependent MCF-7 cell proliferation 
assay and had preferential agonist activity towards ERβ [6]. 
In accordance with our results, 2∼3 g dry matter per day was 
found to increase the weight of immature rat uteri [18]. In 
an ovariectomized uterotrophic adult rat model, T. pratense 
extract was reported to be weakly estrogenic; however, this 
effect was based mainly on the semi-quantitative results of 
the Allen-Doisy vaginal cell cornification assay. Although, 
the highest dose (750 mg/kg per day) of T. pratense extract 
slightly increased uterine weight, it is not clear whether this 
difference was statistically significant compared to the 
control group [7]. In another study, ovariectomized adult rats 
were treated for 21 days with 4, 40, or 400 mg/kg per day 
of T. pratense extract. Neither uterine weight nor vaginal 
cornification assay results were significantly altered [18]. It 
is possible that rats at this perinatal period are more sensitive 
to estrogenic stimuli than adults. Thus, the timing and/or 
route of administration of T. pratense may account for 
differences in results.
In the current study, morphometric analysis showed that 
the number of uterine glands found in the endometrium was 
significantly increased in both the T. pratense and estradiol 
groups. In accordance with our study, Foth and Cline [10] 
reported that diet containing soy protein isolates (SPI) given 
together with estradiol increased endometrial thickness, 
gland area, and epithelial proliferation in macaque monkeys. 
Interestingly, in their study, the effect of estradiol on 
proliferation was partially antagonized by SPI. In our study, 
the area of endometrium showed an increase in treated 
groups, but the total area (epithelium plus myometrium) of 
the uterus was not significantly different than that of the 
control group. Furthermore, the luminal epithelial cell 
height increased in both T. pratense and estradiol treated 
groups. In a study by Overk et al. [18], no data on luminal Effects of T. pratense on rat uterus    125
Fig. 2. ERα (A) and PR (B) immunostaining score in the uterus 
of 21-day-old rats. The proportion of positively stained cells was
scored as follows: 0, none; 1, weak; 2, moderate; 3, strong; 4, 
intense staining.
epithelial cells were presented in rats treated with T. 
pratense. Increased epithelial height indicates hypertrophy 
of the cells. Water imbibition, mainly in the endometrium, 
may be responsible for uterine weight increase even though 
histological observation indicated no evidence of edema in 
the uterine wall. Although we did not measure the 
proliferation index, it is also possible that increased cell 
proliferation in epithelial as well as stromal cells may be 
responsible for the increased thickness of the endometrium.
The expression of PR is under the control of estrogen and 
progesterone [13]. PR is a classic gene marker for estrogen 
action containing estrogen response elements in the 5’ 
region. Estrogen increases PR expression while progesterone 
decreases its expression in most target tissues. Progesterone 
treatment can oppose the estrogen induction of PR and 
progesterone has been shown to decrease total PR 
expression in the uterus [17]. In the current study ERα and 
PR expression was detected by immunohistochemistry. Our 
results revealed that neither T. pratense nor estradiol 
significantly altered the expression of ERα or PR in the 
luminal and glandular epithelium, which could be due to the 
fact that only five animals from each group were analyzed. 
In a study by Cotroneo et al. [9], no significant alteration was 
detected in ERα expression by Western blot analysis or 
immunohistochemistry after dietary administration of 
genistein and estradiol to Sprague Dawley rats. However, 
a decrease in staining intensity was evident when 
pharmacological doses were given by injection. In line with 
our results, they demonstrated that PR expression was not 
altered by dietary genistein administration, but the injection 
of pharmacological doses of both genistein and estradiol 
increased PR expression as shown by Western blot analysis. 
Our results revealed that consumption of T. pratense via 
the oral maternal route caused estrogen-like biological 
effects on the genital organs of rats, namely increased 
uterine weight and luminal epithelial cell height. However, 
no significant changes were detected during 
immunohistochemical evaluation of ERα and PR levels. 
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